These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


151 related items for PubMed ID: 20515759

  • 1. Smad anchor for receptor activation (SARA) in TGF-beta signaling.
    Tang WB, Ling GH, Sun L, Liu FY.
    Front Biosci (Elite Ed); 2010 Jun 01; 2(3):857-60. PubMed ID: 20515759
    [Abstract] [Full Text] [Related]

  • 2. Role of SARA (SMAD anchor for receptor activation) in maintenance of epithelial cell phenotype.
    Runyan CE, Hayashida T, Hubchak S, Curley JF, Schnaper HW.
    J Biol Chem; 2009 Sep 11; 284(37):25181-9. PubMed ID: 19620243
    [Abstract] [Full Text] [Related]

  • 3. The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells.
    Runyan CE, Schnaper HW, Poncelet AC.
    J Biol Chem; 2005 Mar 04; 280(9):8300-8. PubMed ID: 15613484
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA.
    Zhao BM, Hoffmann FM.
    Mol Biol Cell; 2006 Sep 04; 17(9):3819-31. PubMed ID: 16775010
    [Abstract] [Full Text] [Related]

  • 5. Focal adhesion molecule Kindlin-1 mediates activation of TGF-β signaling by interacting with TGF-βRI, SARA and Smad3 in colorectal cancer cells.
    Kong J, Du J, Wang Y, Yang M, Gao J, Wei X, Fang W, Zhan J, Zhang H.
    Oncotarget; 2016 Nov 15; 7(46):76224-76237. PubMed ID: 27776350
    [Abstract] [Full Text] [Related]

  • 6. Smad Anchor for Receptor Activation Regulates High Glucose-Induced EMT via Modulation of Smad2 and Smad3 Activities in Renal Tubular Epithelial Cells.
    Tang WB, Ling GH, Sun L, Zhang K, Zhu X, Zhou X, Liu FY.
    Nephron; 2015 Nov 15; 130(3):213-20. PubMed ID: 26159183
    [Abstract] [Full Text] [Related]

  • 7. The FYVE domain in Smad anchor for receptor activation (SARA) is sufficient for localization of SARA in early endosomes and regulates TGF-beta/Smad signalling.
    Itoh F, Divecha N, Brocks L, Oomen L, Janssen H, Calafat J, Itoh S, Dijke Pt Pt.
    Genes Cells; 2002 Mar 15; 7(3):321-31. PubMed ID: 11918675
    [Abstract] [Full Text] [Related]

  • 8. SMURF2 and SMAD7 induce SARA degradation via the proteasome.
    Wojtowicz S, Lee S, Chan E, Ng E, Campbell CI, Di Guglielmo GM.
    Cell Signal; 2020 Aug 15; 72():109627. PubMed ID: 32283253
    [Abstract] [Full Text] [Related]

  • 9. The FYVE domain of Smad Anchor for Receptor Activation (SARA) is required to prevent skin carcinogenesis, but not in mouse development.
    Chang HM, Lin YY, Tsai PC, Liang CT, Yan YT.
    PLoS One; 2014 Aug 15; 9(8):e105299. PubMed ID: 25170969
    [Abstract] [Full Text] [Related]

  • 10. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor.
    Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL.
    Cell; 1998 Dec 11; 95(6):779-91. PubMed ID: 9865696
    [Abstract] [Full Text] [Related]

  • 11. ERBIN is a new SARA-interacting protein: competition between SARA and SMAD2 and SMAD3 for binding to ERBIN.
    Sflomos G, Kostaras E, Panopoulou E, Pappas N, Kyrkou A, Politou AS, Fotsis T, Murphy C.
    J Cell Sci; 2011 Oct 01; 124(Pt 19):3209-22. PubMed ID: 21878490
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
    Yang F, Chung AC, Huang XR, Lan HY.
    Hypertension; 2009 Oct 01; 54(4):877-84. PubMed ID: 19667256
    [Abstract] [Full Text] [Related]

  • 13. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling.
    Goto D, Nakajima H, Mori Y, Kurasawa K, Kitamura N, Iwamoto I.
    Biochem Biophys Res Commun; 2001 Mar 01; 281(5):1100-5. PubMed ID: 11243848
    [Abstract] [Full Text] [Related]

  • 14. Smad Anchor for Receptor Activation and Phospho-Smad3 Were Upregulated in Patients with Temporal Lobe Epilepsy.
    Zhang W, Du Y, Zou Y, Luo J, Lü Y, Yu W.
    J Mol Neurosci; 2019 May 01; 68(1):91-98. PubMed ID: 30847724
    [Abstract] [Full Text] [Related]

  • 15. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
    Chen H, Yang T, Wang MC, Chen DQ, Yang Y, Zhao YY.
    Phytomedicine; 2018 Mar 15; 42():207-218. PubMed ID: 29655688
    [Abstract] [Full Text] [Related]

  • 16. Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms.
    Neil JR, Johnson KM, Nemenoff RA, Schiemann WP.
    Carcinogenesis; 2008 Nov 15; 29(11):2227-35. PubMed ID: 18725385
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. TGF beta receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2.
    Hayes S, Chawla A, Corvera S.
    J Cell Biol; 2002 Sep 30; 158(7):1239-49. PubMed ID: 12356868
    [Abstract] [Full Text] [Related]

  • 19. PP1 binds Sara and negatively regulates Dpp signaling in Drosophila melanogaster.
    Bennett D, Alphey L.
    Nat Genet; 2002 Aug 30; 31(4):419-23. PubMed ID: 12134149
    [Abstract] [Full Text] [Related]

  • 20. Analysis of transforming growth factor β signaling in chronic rhinosinusitis.
    Li YC, An YS, Wang T, Zang HR.
    Chin Med J (Engl); 2013 Aug 30; 126(17):3340-3. PubMed ID: 24033961
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.